Market problem: 1.1 B people suffer from migraines globally (100M+ in EU). Nearly 60% are dissatisfied with drug-based treatments.
Market gap: Low-cost wellness devices (<€150) vs. high-priced clinical neurostimulators (>€500). Migraineer targets the underserved mid-market (€200–€300) with a wearable + SaaS app.
Validation: Initial focus on EU for digital operations, measuring conversion, retention, and satisfaction to achieve product-market fit.